In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
Privately-held Swiss drugmaker Helsinn Group has announced the appointment of Dr Melanie Rolli as group chief operating officer (COO), effective June 1, 2022. 19 May 2022
Pharmaceutical
German firm Fresenius Kabi, a specialist in medicines and technologies for infusion, transfusion and clinical nutrition, has recruited Brandee Pappalardo as senior vice president and chief medical officer for North America. 19 May 2022
Pharmaceutical
Cerevance, a private, UK headquartered clinical-stage drug discovery and development company focused on central nervous system diseases, today announced the appointment of Craig Thompson as chief executive (CEO). 20 April 2022
Pharmaceutical
Danish CNS specialist Lundbeck said on Friday it has has appointed Joerg Hornstein as chief financial officer (CFO) and member of its executive management. He will assume the role no later than September 1, 2022, and he will be registered with the Danish Business Authority. 11 April 2022
Pharmaceutical
Swiss pharma giant Novartis has announced the introduction of a new, simpler organizational structure and operating model. 4 April 2022
Pharmaceutical
UK endocrine diseases specialist Diurnal Group today announced that, following 14 years with the company, Martin Whitaker has decided to step down as chief executive (CEO) and a member of the board of Diurnal, with immediate effect, to enable him to pursue other business opportunities. 4 April 2022
Pharmaceutical
US pharma giant Merck & Co today announced today that Dr Roy Baynes, head of global clinical development (GCD) and chief medical officer, Merck Research Laboratories (MRL), will be retiring from Merck in July. 23 March 2022
Pharmaceutical
The end of an era is approaching at Anglo-Swedish drugmaker AstraZeneca as Leif Johansson, non-executive chairman of the board, confirmed that he will be retiring in 2023. 23 February 2022
Pharmaceutical
US cancer therapies specialist Karyopharm Therapeutics saw its shares drop as much as 31% Tuesday, on the news that its chief medical officer was stepping down, even though it also announced two prominent research appointments. 23 February 2022
Pharmaceutical
Danish dermatology specialist LEO Pharma has appointed Brian Hilberdink new executive vice president and president of LEO Pharma Inc in the USA, effective March 14, 2022. 21 February 2022
Pharmaceutical
US pharma giant Merck & Co has announced new leadership for its Human Health business. 17 February 2022
Pharmaceutical
The UK business of New York-based pharma giant Pfizer has appointed Susan Rienow as managing director. 14 February 2022
Pharmaceutical
UK-based respiratory disease specialist Enterprise Therapeutics has appointed Niyati Prasad as chief medical officer. 8 February 2022
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceuticals today announced changes to its Growth and Emerging Markets Business Unit (GEM BU) leadership team as part of the company’s broader corporate leadership team changes to accelerate business growth and the delivery of transformational medicines to patients. 7 February 2022
Pharmaceutical
GlaxoSmithKline’s Christine Roth is to leave the company to become the new head of the Oncology Strategic Business Unit at Bayer’s (BAYN: DE) Pharmaceuticals division. 4 February 2022
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceutical today announced changes to its executive leadership team to continue driving long-term growth in a highly competitive and dynamic global marketplace. 3 February 2022
Pharmaceutical
Swiss pharma giant Roche today announced that Dr William Pao, head of Roche pharma research and early development (pRED) since 2018, has decided to leave Roche for a new opportunity and return to the USA, effective March 18, 2022. 2 February 2022
Pharmaceutical
Once touted as a potential successor to Merck & Co’s former boss Kenneth Frazier, Frank Clyburn is to leave his post as the company’s executive vice president and president, Human Health, to take up a role elsewhere. 21 January 2022
Pharmaceutical
German life sciences company Merck KGaA today announced new appointments in global R&D and strategy leadership for the Healthcare business sector. 13 January 2022
Pharmaceutical
Privately-held Danish medical dermatology specialist LEO Pharma today said that its president and chief executive of two years, Catherine Mazzacco, has resigned from the position and will be leaving the company as of today. 30 November 2021
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze